166 results on '"Rowley, Jared"'
Search Results
2. Geographic Employment Outcomes for Graduating Residents in Radiation Oncology: 2021
3. Gender representation among academic US radiation oncology department chairs: who are they?
4. The Holman Research Pathway in Radiation Oncology: 2010 to 2019
5. Radiation Oncology Resident Research Productivity in the United States: 2015 to 2019
6. Gender Differences in the Research Productivity of Radiation Oncology Resident Graduates in the United States: 2015 to 2019
7. The Rise of Open Access Journals in Radiation Oncology: Influence on Resident Research, 2015 to 2019
8. Dynamic Amyloid and Metabolic Signatures of Delayed Recall Performance within the Clinical Spectrum of Alzheimer’s Disease
9. Oligoprogression of Solid Tumors on Immune Checkpoint Inhibitors: The Impact of Local Ablative Radiation Therapy
10. Characterization of age/sex and the regional distribution of mGluR5 availability in the healthy human brain measured by high-resolution [11C]ABP688 PET
11. In Regard to Huang et al.
12. In Regard to Mattes et al.
13. Moving beyond Definitive Therapy: Increasing Physical Activity in Survivors of Cancers of the Head and Neck
14. Characterization of rib fracture development following liver directed stereotactic body radiation therapy
15. In vivo hippocampal cornu ammonis 1–3 glutamatergic abnormalities are associated with temporal lobe epilepsy surgery outcomes
16. In Reply to Jones et al
17. In vivo and in vitro Validation of Reference Tissue Models for the mGluR5 Ligand [11C]ABP688
18. Inferior Longitudinal Fasciculus’ Role in Visual Processing and Language Comprehension: A Combined MEG-DTI Study
19. Patterns of care and outcomes of intensity modulated radiation therapy versus three-dimensional conformal radiation therapy for anal cancer
20. Focal mGluR5 Abnormalities Identified in vivo in Mesial Temporal Lobe Epilepsy (MTLE) by [11C]ABP688 Positron Emission Tomography (PET) (S36.002)
21. In vivo metabotropic glutamate receptor type 5 abnormalities localize the epileptogenic zone in mesial temporal lobe epilepsy
22. White matter abnormalities and structural parietal disconnections in Alzheimer's disease
23. White Matter Abnormalities and Structural Hippocampal Disconnections in Amnestic Mild Cognitive Impairment and Alzheimer’s Disease
24. Resting state executive control network adaptations in amnestic mild cognitive impairment
25. Association between memory and amyloid deposition–synaptic dysfunction in people with EMCI, LMCI and Alzheimer’s disease
26. Association between cortical thickness and CSF biomarkers in mild cognitive impairment and Alzheimer’s disease
27. Characterization of age/sex and the regional distribution of mGluR5 availability in the healthy human brain measured by high-resolution [11C]ABP688 PET
28. P4-302: PARIETAL WHITE MATTER TRACT ALTERATIONS IN MCI AND ALZHEIMER'S DISEASE PATIENTS FROM THE ADNI DATASET
29. P4-132: WHITE MATTER ABNORMALITIES AND STRUCTURAL PARIETAL DISCONNECTIONS IN ALZHEIMER'S DISEASE
30. IC-P-134: WHITE MATTER ABNORMALITIES AND STRUCTURAL PARIETAL DISCONNECTIONS IN ALZHEIMER'S DISEASE
31. Resting State Executive Control Network Adaptations in Amnestic Mild Cognitive Impairment
32. IC-P-029: Association between memory and amyloid deposition-synaptic dysfunction in people with EMCI, LMCI and Alzheimer's disease
33. IC-P-025: [18F]NAV4694 shows higher binding and wider dynamic range compared with [11C]PiB in Alzheimer's disease postmortem tissue
34. P3-083: Differential impact of amyloidosis and tau pathology on brain metabolism
35. DT-02-05: In vivo characterization of metabotropic glutamate receptor type five vulnerability in behavioral variant FTD and Alzheimer's disease: An [11 C]ABP688 PET/ VBM /DBM study
36. IC-P-125: Posterior cingulate network adaptation in Alzheimer's disease
37. IC-P-115: Association between cortical thickness and CSF biomarkers in mild cognitive impairment and Alzheimer's disease
38. P1–198: Association between cortical thickness and CSF biomarkers in mild cognitive impairment and Alzheimer's disease
39. IC‐P‐012: Differential impact of amyloidosis and tau pathology on brain metabolism
40. IC-O3-04: In vivo characterization of glutamatergic vulnerability in behavioral variant FTD: An [11C]ABP688 PET/ VBM /DBM study
41. P2-186: Resting state executive control network adaptations in amnestic mild cognitive impairment
42. O5-02-03: Regional distribution of brain fibrillar amyloid deposition as a function of CSF beta-amyloid 1-42 and biomarkers of neurodegeneration
43. O1-04-03: Association between memory and amyloid deposition and synaptic dysfunction in EMCI, LMCI and Alzheimer's disease patients
44. P2-125: Posterior cingulate network adaptation in Alzheimer's disease
45. IC-P-011: Regional distribution of fibrillar amyloid deposition in the brain as a function of CSF beta-amyloid 1-42 and biomarkers of neurodegeneration
46. P3–091: [18F]NAV4694 shows higher binding and wider dynamic range compared with [11C]PiB in Alzheimer's disease postmortem tissue
47. Characterization of age/sex and the regional distribution of mGluR5 availability in the healthy human brain measured by high-resolution [C]ABP688 PET.
48. P3-185: Regional patterns of amyloidosis and synaptic dysfunction associated with auditory verbal learning: A PET study utilizing FDG and AV45 from ADNI
49. P4-330: Association of brain amyloidosis and metabolism with the Trail Making Test in MCI and Alzheimer's disease
50. P3‐096: Brain beta‐amyloid deposition and metabolism in early and late mild cognitive impairment
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.